(Reuters) - Pfizer Inc (PFE.N) agreed on Wednesday to buy Baxter International Inc's (BAX.N) vaccines unit and a part of a production facility for $635 million.
The deal will give Pfizer access to Baxter's meningitis vaccine, NeisVac-C, and its encephalitis vaccine, FSME-IMMUN.
07:16 Aroldis Chapman Acquired by Yankees in Five-Year, $86 Million Deal11
07:16 Aroldis Chapman, Yankees agree to five-year, $86 million record deal9
06:10 Sources: Carlos Gomez, Rangers agree on 1-year, $11.5 million deal18
22:35 Bryce Harper's request for record $400 million deal too much for Nationals: report3